Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study T Wimberley, H Støvring, HJ Sørensen, HT Horsdal, JH MacCabe, ... The Lancet Psychiatry 3 (4), 358-366, 2016 | 174 | 2016 |
Mortality and self-harm in association with clozapine in treatment-resistant schizophrenia T Wimberley, JH MacCabe, TM Laursen, HJ Sørensen, A Astrup, ... American Journal of Psychiatry 174 (10), 990-998, 2017 | 139 | 2017 |
Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study AP Rajkumar, HT Horsdal, T Wimberley, D Cohen, O Mors, AD Børglum, ... American Journal of Psychiatry 174 (7), 686-694, 2017 | 137 | 2017 |
Polygenic risk score for schizophrenia and treatment-resistant schizophrenia T Wimberley, C Gasse, SM Meier, E Agerbo, JH MacCabe, HT Horsdal Schizophrenia bulletin 43 (5), 1064-1069, 2017 | 105 | 2017 |
Association of secondary preventive cardiovascular treatment after myocardial infarction with mortality among patients with schizophrenia P Kugathasan, HT Horsdal, J Aagaard, SE Jensen, TM Laursen, ... JAMA psychiatry 75 (12), 1234-1240, 2018 | 84 | 2018 |
Genetic liability to ADHD and substance use disorders in individuals with ADHD T Wimberley, E Agerbo, HT Horsdal, C Ottosen, I Brikell, TD Als, ... Addiction 115 (7), 1368-1377, 2020 | 75 | 2020 |
C-reactive protein and white blood cell levels in schizophrenia, bipolar disorders and depression-associations with mortality and psychiatric outcomes: a population-based study HT Horsdal, O Köhler-Forsberg, ME Benros, C Gasse European Psychiatry 44, 164-172, 2017 | 63 | 2017 |
Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study L Bjørklund, HT Horsdal, O Mors, SD Østergaard, C Gasse Acta Neuropsychiatrica 28 (2), 75-84, 2016 | 55 | 2016 |
Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study HT Horsdal, SP Johnsen, F Søndergaard, J Jacobsen, RW Thomsen, ... Diabetes/metabolism research and reviews 25 (6), 515-522, 2009 | 50 | 2009 |
Otitis media, antibiotics, and risk of autism spectrum disorder T Wimberley, E Agerbo, CB Pedersen, S Dalsgaard, HT Horsdal, ... Autism Research 11 (10), 1432-1440, 2018 | 47 | 2018 |
Identification of genetic loci associated with nocturnal enuresis: a genome-wide association study CS Jørgensen, HT Horsdal, VM Rajagopal, J Grove, TD Als, K Kamperis, ... The Lancet Child & Adolescent Health 5 (3), 201-209, 2021 | 44 | 2021 |
Association of childhood exposure to nitrogen dioxide and polygenic risk score for schizophrenia with the risk of developing schizophrenia HT Horsdal, E Agerbo, JJ McGrath, BJ Vilhjálmsson, S Antonsen, ... JAMA network open 2 (11), e1914401-e1914401, 2019 | 44 | 2019 |
Association between childhood green space, genetic liability, and the incidence of schizophrenia K Engemann, CB Pedersen, E Agerbo, L Arge, AD Børglum, C Erikstrup, ... Schizophrenia Bulletin 46 (6), 1629-1637, 2020 | 41 | 2020 |
Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study HT Horsdal, AV Olesen, C Gasse, HT Sørensen, RC Green, SP Johnsen Alzheimer Disease & Associated Disorders 23 (1), 18-22, 2009 | 38 | 2009 |
Psychopharmacological drug utilization patterns in pregnant women with bipolar disorder–A nationwide register-based study SC Broeks, HT Horsdal, KG Ingstrup, C Gasse Journal of Affective Disorders 210, 158-165, 2017 | 37 | 2017 |
Temporally ordered associations between type 2 diabetes and brain disorders–a Danish register-based cohort study T Wimberley, HT Horsdal, I Brikell, TM Laursen, A Astrup, G Fanelli, ... BMC psychiatry 22 (1), 573, 2022 | 36 | 2022 |
Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia O Köhler, HT Horsdal, L Baandrup, O Mors, C Gasse Clinical epidemiology, 323-332, 2016 | 34 | 2016 |
Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case–control study HT Horsdal, F Søndergaard, SP Johnsen, J Rungby Pharmacoepidemiology and drug safety 20 (4), 331-337, 2011 | 34 | 2011 |
Lifestyle profile among statin users RW Thomsen, RB Nielsen, M Nørgaard, HT Horsdal, T Stürmer, ... Epidemiology 24 (4), 619-620, 2013 | 33 | 2013 |
Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia C Gasse, T Wimberley, Y Wang, O Mors, A Børglum, TD Als, T Werge, ... Schizophrenia Research 212, 79-85, 2019 | 32 | 2019 |